Pharma giant AstraZeneca (AZN) is transitioning its U.S. listing by delisting American Depositary Shares (ADS) from Nasdaq and directly listing its ordinary shares on the New York Stock Exchange (NYSE ...

Data centers have caused the demand for gas-fired power in the US to explode over the past two years, according to new research released Wednesday. More than a third of this new demand, the research ...

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the ...

A milestone that demonstrates how Roxi's AI-powered insight, delivered through Giatec SmartMix, is helping concrete producers improve quality, reduce variability, and achieve measurable cost savings ...

Forbes contributors publish independent expert analyses and insights. Julia Korn writes about leadership and career development. This voice experience is generated by AI. Learn more. This voice ...

WASHINGTON—Microsoft MSFT-0.08%decrease; red down pointing triangle promised to pay higher utility bills for all of its U.S. data centers powering artificial-intelligence models, a pledge that drew ...

The USD1 stablecoin added $150 million to its market capitalization after Binance announced an incentive program offering up to 20% yield. The World Liberty Financial USD (USD1) stablecoin linked to ...

The NCAA Transfer Portal does not officially open until Jan. 2, and once it does, the window will remain open for two weeks through Jan. 16. Despite that, several players across college football have ...

A new bar and event venue is headed to the former Castro/Duboce Triangle dive bar Lucky 13 at 2140 Market Street. Hoodline was alerted to the change by a liquor license application notice on the ...

The following slide deck was published by Structure Therapeutics Inc. in conjunction with this event.

Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...